VITIELLO, LIBERO
 Distribuzione geografica
Continente #
NA - Nord America 6.419
EU - Europa 943
AS - Asia 923
AF - Africa 3
SA - Sud America 1
Totale 8.289
Nazione #
US - Stati Uniti d'America 6.409
CN - Cina 484
SG - Singapore 277
IT - Italia 217
DE - Germania 177
FI - Finlandia 139
SE - Svezia 136
VN - Vietnam 105
FR - Francia 76
UA - Ucraina 68
GB - Regno Unito 49
IN - India 30
NL - Olanda 21
IE - Irlanda 18
HK - Hong Kong 13
RU - Federazione Russa 11
AT - Austria 6
BE - Belgio 6
CA - Canada 6
GR - Grecia 6
SA - Arabia Saudita 4
CH - Svizzera 3
PT - Portogallo 3
TR - Turchia 3
CU - Cuba 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IR - Iran 2
NO - Norvegia 2
ZA - Sudafrica 2
BR - Brasile 1
EG - Egitto 1
ES - Italia 1
GT - Guatemala 1
IQ - Iraq 1
JP - Giappone 1
LU - Lussemburgo 1
MX - Messico 1
RS - Serbia 1
TH - Thailandia 1
Totale 8.289
Città #
Fairfield 820
Woodbridge 685
Ann Arbor 644
Chandler 644
Houston 509
Ashburn 404
Jacksonville 301
Wilmington 301
Seattle 280
Cambridge 269
Singapore 230
Santa Clara 214
Boardman 164
Princeton 145
Beijing 130
Dong Ket 104
Roxbury 84
San Diego 76
Medford 72
Padova 70
Des Moines 66
Nanjing 57
Helsinki 54
Milan 27
Shenyang 27
Guangzhou 19
Dublin 18
Nanchang 18
Falls Church 17
Hebei 17
Jiaxing 17
New York 17
Changsha 14
Hong Kong 13
Norwalk 12
Rome 12
Nürnberg 10
Jinan 9
London 9
Munich 9
Tianjin 9
Florence 8
Redwood City 8
Shanghai 8
Washington 8
Hangzhou 7
Los Angeles 7
Detroit 6
Göttingen 6
Paris 6
Vienna 6
Zhengzhou 6
Amersfoort 5
Borås 5
Rockville 5
Chennai 4
Indiana 4
Kunming 4
Lanzhou 4
Riyadh 4
Tappahannock 4
Agrate Brianza 3
Chicago 3
Civitavecchia 3
Dallas 3
Ghent 3
Kharar 3
Kharkiv 3
Kilburn 3
Mestre 3
Ningbo 3
Phoenix 3
Pune 3
Surat 3
Taiyuan 3
Turin 3
Verona 3
Xi'an 3
Acton 2
Amsterdam 2
Auburn Hills 2
Bologna 2
Brescia 2
Castel San Giovanni 2
Chengdu 2
Council Bluffs 2
Frankfurt am Main 2
Haikou 2
Havana 2
Hefei 2
Hyderabad 2
Istanbul 2
Lappeenranta 2
Leawood 2
Liverpool 2
Memphis 2
Mestrino 2
Muggiò 2
Nuremberg 2
Poggio Renatico 2
Totale 6.807
Nome #
A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in the TP63 gene in patients with arrhythmogenic cardiomyopathy 190
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 171
Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation 165
Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization? 141
Satellite cells delivered by micro-patterned scaffolds: a new strategy for cell transplantation in muscle diseases 136
In vivo delivery of naked antisense oligos in aged mdx mice analysis of dystrophin restoration in skeletal and cardiac muscle 136
Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients 136
Secretion-Positive LGI1 Mutations Linked to Lateral Temporal Epilepsy Impair Binding to ADAM22 and ADAM23 Receptors 134
A study on duplications of the dystrophin gene: Evidence of a geographical difference in the distribution of breakpoints by intron 133
Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle 132
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo 131
Gene delivery as a new therapeutic approach 127
Selection of multipotent cells and enhanced muscle reconstruction by myogenic macrophage-secreted factors. 126
A Novel Loss-of-Function LGI1 Mutation Linked to Autosomal Dominant Lateral Temporal Epilepsy 126
Designing a 3D printed human derived artificial myo-structure for anal sphincter defects in anorectal malformations and adult secondary damage 121
Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma. 115
A study on duplications of the dystrophin gene: evidence of a geographical difference in the distribution of breakpoints by intron. 112
Efficient delivery of human single fiber-derived muscle precursor cells via biocompatible scaffold 110
Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients 110
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 107
A 3′ consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions 107
Low penetrance and effect on protein secretion of LGI1 mutations causing autosomal dominant lateral temporal epilepsy 105
A 3' consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions. 105
A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signaling and miRNA dysregulation. 104
DXS997 localized to intron 48 of dystrophin 103
Engineering a 3D in vitro model of human skeletal muscle at the single fiber scale 103
Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization 102
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 100
Dystrophin-positive fibers in duchenne dystrophy: Origin and correlation to clinical course 99
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 99
Screening for mutations in the muscle promoter region and for exonic deletions in a series of 115 DMD and BMD patients. 98
Commitment of Autologous Human Multipotent Stem Cells on Biomimetic Poly-L-lactic Acid-Based Scaffolds Is Strongly Influenced by Structure and Concentration of Carbon Nanomaterial 98
Genomic organization of the human dystrophin gene across the major deletion hot spot & the 3' region 97
Enhancing myoblast proliferation by using myogenic factors: a promising approach for improving fiber regeneration in sport medicine and skeletal muscle diseases 97
Electrophysiologic stimulation improves myogenic potential of muscle precursor cells grown in a 3D collagen scaffold 97
Cardiac involvement in Becker muscular dystrophy 97
In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. 96
Culture of satellite cells in an electrically-stimulated three-dimensional scaffold for the generation of skeletal muscle engineered graft 92
A novel nonsense mutation in the human dystrophin gene 90
The Rag2–Il2rb–Dmd– mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies 90
Reappraisal of the incidence rate of Duchenne and Becker muscular dystrophies on the basis of molecular diagnosis. 89
Murine Muscle Precursor Cells survived and integrated in a Cryoinjured Gastroesophageal Junction. 89
Immune-Privileged Sites within Skeletal Muscle: Apoptosis of FasL-Transfected Myoblasts Prevents the Formation of FasL-Expressing Muscle Fibers In Vivo 83
Muscle tissue engineering using single fiber isolation technique: in vitro and in vivo perspectives 83
Characterization of myogenic factors derived from a stable macrophage cell line 82
Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma 82
Transfection of cultured myoblasts in high serum concentration with DODAC: DOPE liposomes 81
Duplication of dystrophin gene and dissimilar clinical phenotype in the same family 81
Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle. 80
Analysis Of Differential Lipofection Efficiency In Primary and Established Myoblasts 80
Muscle tissue engineering using single fibre isolation technique: in vitro and in vivo prospectives 77
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. 77
Macrophage-secreted factors enhance the in vitro expansion of DMD muscle precursor cells while preserving their myogenic potential 77
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 75
Functional differentiation of satellite stem cells by topological and electric stimuli 74
Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells 73
Physiological electrical stimuli control in vitro satellite cell differentiation 73
Novel Missense Variant in MYL2 Gene Associated with Hypertrophic Cardiomyopathy Showing High Incidence of Restrictive Physiology 73
Corrigenda: DXS997 localized to intron 48 of dystrophin (Human Molecular Genetics (1993) 2 (2199)) 72
Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: an Age- and Muscle-related Reappraisal 72
Detection of unknown gene mutations by multiplex single-strand conformation polymorphism (MSSCP). 70
Systemic delivery of therapeutic nucleic acids into skeletal muscle by means of lipid-based vectors 69
ENGINEERING A 3D IN VITRO MODEL OF HUMAN SKELETAL MUSCLE 68
La medicina predittiva e il dibattito etico sui test genetici 68
Quantitative study of satellite cell differentiation by electrophysiological stimuli 67
Occurrence of two different intragenic deletions in two male relatives affected with Duchenne muscular dystrophy. 67
Muscle tissue micro engineering 67
The LGI1/Epitempin gene encodes two protein isoforms differentially expressed in human brain 63
3D Printed Graphene-PLA Scaffolds Promote Cell Alignment and Differentiation 63
A report on 528 intragenic deletions detected in DMD and BMD patients by an Italian collaborative study. 62
Dystrophin restoration in mdx mice transplanted with wt satellite cells 60
Satellite cells delivered by polymer: a new strategy in muscle cell therapy 59
MACROPHAGE-DERIVED MYOGENIC FACTORS AS A TOOL FOR CELL THERAPY IN DYSTROPHIC MUSCLE 59
Gene Transfer In Skeletal Muscle By Systemic Injection Of DODAC Lipopoliplexes 58
Functionally antagonistic groups of macrophages can be incorporated with human pluripotent stem-cell derived cardiomyocytes to engineer a novel human myocardial infarction model in vitro. 55
Transcriptional analysis of micropatterned muscle cells stimulated 54
Regulatory mutations in transforming growth factor-beta 3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 53
In vivo tissue engineering of functional skeletal muscle by satellite cells delivered in a photo-polymerizable hydrogel 53
Chronic systemic curcumin administration antagonizes murine sarcopenia and presarcopenia 53
The neuro-cardiac interaction defines an extracellular microdomain required for neurotrophic signaling 52
Patterns of deletions of the dystrophin gene in different European populations. 52
Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures 52
The Rag2-/-Il2rb-/-Dmd-/- mouse model: a new kick-off for human myogenic stem cells transplantation 50
Preparation and biological studies of pegylated epirubicin 50
Characterization of powerful myogenic factors present in media conditioned by murine or human macrophages 49
Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy 48
Synthesis and biological studies of PEG-epirubicin conjugates 46
Culture of satellite cells in electrical stimulated 3D collagen scaffold for the creation of skeletal-muscle engineered graft 46
Gene therapy for muscular dystrophy - Early experiments with liposome-mediated gene transfer 46
Biofabricating murine and human myo-substitutes for rapid volumetric muscle loss restoration 46
Comparison of knock-in mouse and hiPSC-based models of arrhythmogenic cardiomyopathy carrying the DSG2 p.Q558* mutation 43
Diagnosis and treatment of cardiac involvement in Becker muscular dystrophy 41
Three ways to try and heal a diseased muscle: macrophages, exon skipping and cell transplantation 40
In vitro engineering of muscle precursor cell niche by mimicking multiple stimuli 35
Skeletal muscle fibers delivered through photopolymerizable hydrogel scaffold improve muscle regeneration 34
IN VIVO DELIVERY OF NAKED AND LIPID-COMPLEXED ANTISENSE OLIGOS IN MDX MICE: EFFECTS ON SKELETAL AND CARDIAC MUSCLE 31
Macrophage-secreted factors enhance the in vitro expansion of DMD muscle precursor cells while preserving their myogenic potential 31
De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle☆ 30
Heart transcriptome profile of a novel transgenic mouse model for arrhythmogenic cardiomyopathy 26
A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in mdx Mice 26
Totale 8.253
Categoria #
all - tutte 30.715
article - articoli 24.822
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 530
Totale 56.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020866 0 0 0 0 0 101 107 150 142 187 115 64
2020/20211.119 45 64 41 97 109 68 24 105 135 142 139 150
2021/20221.327 27 162 191 76 43 89 66 181 49 13 141 289
2022/20231.225 226 148 28 180 180 160 7 76 149 7 44 20
2023/2024616 19 90 71 47 61 61 40 36 8 35 72 76
2024/2025854 17 181 107 115 362 72 0 0 0 0 0 0
Totale 8.351